Cancer Diagnostics Conference and Expo 2016

Posted on 2016-03-24 by EPR Network in Education, Healthcare // 0 Comments

Rome, Italy, March 24, 2016 — /EPR NETWORK/ — OMICS International Conferences invites all the participants from all over the globe to attend ‘‘Cancer Diagnostics Conference and Expo’’ during June 13-15, 2016 in Rome, Italy which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Cancer Diagnostics 2016 is a global Cancer conference which discuss about the latest and recent advancements in the diagnosis and the treatment of cancer and deals about various researches going on in cancer diagnostics.

Track 1: Cancer Diagnostics Market:

Advanced diagnostics technologies have achieved a reduction of 30% in reduction due to breast cancer. Hence, the imaging sector in the global Oncological diagnostics market will continue its everlasting in the foreseeable future. The world-wide Cancer Diagnostics market can be segmented into blood cancer, kidney cancer, breast cancer, prostate cancer, pancreatic cancer, ovarian cancer, lung cancer, and liver cancer. The global cancer diagnostics market is mostly driven by enhancing the demand for lung cancer and breast cancer diagnosis. The Pulmonary cancer segment is leading the market, as it is the very popular type of cancer. Cancer Diagnostics 2016 is a very prestigious gathering across global Cancer Conferences.

Related Conferences: 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta USA; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 2016 ARRS Lung cancer Annual Meeting April 12-16, 2016 Los Angeles, USA; NEO 16-“New and Emerging Trends In Oncology Conferences 2016, February 10-12, 2016 Hyderabad, India; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany; Cancer-2016 — International Cancer Study & Therapy Conference April 4-6, 2016 Baltimore, USA

Track 2: Cancer Diagnostics Types:

Mammogram is used to image and X-ray of the Breast. While screening mammograms are routinely administered to detect breast cancer in women who has no apparent signs, diagnostic systems are used after suspicious results on a screening mammogram has some symptoms of breast cancer alert the Oncologist to check that tissue.

An ultrasound wand is inserted in vagina and to see at the ovaries. An ultrasound produces sound waves that induces imaging of the ovaries, including cysts, and Oocytes. Researchers are currently studying whether this test can help with early detection of ovarian cancer.

A breast biopsy is a test that cut tissue fluid from the breast. The removed cells are tested under a microscope and later checked for whether there is breast cancer. OMICS International Conferences organizes large number of Cancer Conferences globally with respect to regions.

Related Conferences: 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA;7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; Personalized Diagnostics February 16-18, 2016 San Francisco, USA; International Agency for Cancer Research 50th Cancer conference, June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; Cancer-2016: A critical review on innovations in the cancer diagnosis and treatment Feb 22-24, 2016 Baltimore, USA

Track 3: Cancer Screening Tests:

Prostate screening tests consists of Digital rectal exam (DRE) and Prostate-specific antigen (PSA) test.

Screening increases the capacity of detecting certain cancers early when they are most likely to be curable. Learn what screening tests the American Cancer associations suggests, when you should have them, and how they are covered under some types of cancer therapies.

Mammograms are used to analyses breast cancer in women who have no signs or symptoms of the disease. Cancer screening Oncolytic is an exciting, increasingly recognized discipline in cancer research which will be discussed in upcoming cancer conferences.

Related Conferences: 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; Personalized Diagnostics February 16-18,2016 San Francisco, USA; 17th International Conference on Lung Cancer December 4-7,2016 Venice, Italy; NEO 16 — “New and Emerging Trends In Oncology 2016 February 10-12, 2016 Hyderabad, India; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany; Cancer-2016 — International Cancer Therapy Conference April 4-6, 2016 Baltimore, USA

Track 4: Cancer Radiology:

Radiological tests can help physicians to find and treat some of cancers early. Early detection is important because when abnormal tissue or cell is found early, it may easier to treat. By the time symptoms appear, cancer may have begun to spread and is very difficult to treat. Several screening tests have been shown to detect cancer early and to decrease the chance of death from that cancer. Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number cases diagnosed in 2012 and become an important topic for World Cancer Conferences.

Related Conferences: 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA;, 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA. International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016, Istanbul, Turkey; NEO 16 – New and Emerging Trends In Oncology May 19-21, 2016 San Francisco, USA; Cancer-2016 International Cancer Study & Therapy April 4-6, 2016 Baltimore, USA;. American Society of Clinical Oncology 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany

Track 5: Cancer Nanotechnology:

Cancer nanotechnology is the burgeoning field of treatment of cancer with nanotechnology. It is applicable for cancer diagnosis, imaging, prognosis and therapy. The nanoparticles selectively accumulate in the tumor cell by the mechanism of the enhanced permeability and retention effect. Thus, nanoparticles are suitable for delivering diagnostic and the imaging agents, chemo and gene drugs to the tumor. Nanoparticles also offer an amplification mechanism for bioanalytical detection and sensor devices for cancer markers. The tumor microenvironment is the cellular environment in which the tumor exists.

Related Conferences: 2nd International Conference on Prostate Cancer and Treatment May 05-07, 2016 Chicago, USA, 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE,;7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA, International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin Germany, International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; NEO 16 – New and Emerging Trends In Oncology May 19-21, 2016 San Francisco, USA; Cancer-2016 International Cancer Therapy April 4-6, 2016 Baltimore, USA;. American Society of Clinical Oncology 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016, Heidelberg, Germany

Track 6: Approaches in Cancer Therapy:

Cancer rates are daily increasing particularly in the developed world. Many cancers are associated with longevity, and as life expectancy increase the risk on patients and payers will increase. Major advances in cellular biology, genetics, pharmacology and immunology in the past ten years are beginning to be translated into progress in cancer treatment. This progress is manifested by new cell killing drugs which have recently entered clinical practice. Tumor angiogenesis as a target is being studied in several clinical trials. The emerging field of genomics and gene expression micro-arrays will provide extensive information about the biology of cancers.

Related Conferences: International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; 5th World conference on Cancer Therapy September 28-30, 2016 Atlanta, USA; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; 4th International Conference on Blood Malignancies and Treatment April 18-20, 2016 Dubai, UAE; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 4th Cancer Epigenetics Conference November 16-17, 2016,San Francisco, USA; NEO 16 – New and Emerging Trends In Oncology May 19-21, 2016 San Francisco, USA; Cancer-2016 International Conference of Cancer Study & Therapy April 4-6, 2016 Baltimore, USA; International Agency for Cancer Research 50th conference June 8-10, 2016 Lyon, France; American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden

Track 7: Predictive Cancer Biomarkers:

A cancer biomarker can be a process substance that indicates the presence of cancer in the body. It may be a molecule secreted by tumor cells or a particular response of the body because of the presence of cancer. Biomarkers may genetic, epigenetic, proteomic, glycomic, or imaging. They can be used for cancer diagnosis, prognosis, medicine, epidemiology of cancer. Those biomarkers that are particularly associated with mutations offer a quantitative way to determine when individuals are predisposed to particular types of cancers. Mutations of genes like BRCA1 and BRCA2 are advanced breast cancer biomarkers, and mutations on genes like KRAS, p53, EGFR, erbB2 are used for colorectal, esophageal, liver, and pancreatic cancer.

Track 8: Cancer Genomics and Epigenetics:

Clinical genomics is the sequencing of genome to inform patient diagnosis and care. Clinical genomics is a new and ever-changing field. Knowledge of the human genome is far from complete, but there are already uses for genetic and genomic information at the physician’s desk. Genome sequencing is expected to have the most impact in: characterizing and detecting the genetic disease; stratifying patients for appropriate cancer treatment; and providing information about an individual’s likely response to reduce adverse drug reactions.

Related Conferences: 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 5th World conference on Cancer Therapy September 28-30, 2016 Atlanta, USA; International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; 4th Cancer Epigenetics Conference November 16-17, 2016 San Francisco, USA; NEO 16 – New and Emerging Trends In Oncology May 19-21, 2016 San Francisco, USA; Cancer-2016 International Cancer Study and Therapy April 4-6, 2016 Baltimore, USA; International Agency for Research on Cancer 50th conference June 8-10, 2016 Lyon, France; American Society of Clinical Oncology conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden

Track 9: Cancer Treatment:

There are several cancer treatments. The types of treatment that you have will depend on the type of person and the type of cancer you have and how it is. Some people with cancer will have only one treatment. But most people have a group of treatments, such as surgery with chemotherapy and/or radiation therapy. Also have immunotherapy, targeted therapy, or hormone therapy.

Related Conferences: International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; 5th World conference on Cancer Therapy September 28-30, 2016 Atlanta, USA; 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; 2nd International Conference on Antimicrobial Agents and Chemotherapy June 06-07, 2016 Dallas, USA; NEO 16 – New and Emerging Trends In Oncology May 19-21, 2016 San Francisco, USA; Cancer-2016 International Cancer Therapy April 4-6, 2016 Baltimore, USA;. American Society of Clinical Oncology Conferences 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany

Track 10: Recent Diagnostics Technologies:

An accurate and full knowledge on cancer diagnosis is the first step in developing an individualized cancer treatment strategy. When you first visit hospital, we will perform a complete array of diagnostic tests to accurately confirm your disease and plan your personal treatment. Diagnostic testing involves tests and procedures to confirm the disease and identify the tumor type, location, extent and stage. Its multidisciplinary approach allows readers to keep up-to-date with challenges and enhancement in their own as well as related fields. Cancer conferences also focused on these topics.

Related Conferences: 11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; NEO 16 – New and Emerging Trends In Oncology May 19-21, 2016 San Francisco, USA; Cancer-2016 International Cancer Study and Therapy April 4-6, 2016 Baltimore, USA;. American Society of Clinical Oncology 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany

Track 11: Organ Specific Cancer:

The name of cancer is based on the location of cancer cells occur in particular organ. There are more than 200 different types of cancer diagnosed. Among them Lung cancer, breast cancer are the most common cancer diagnosed cancer in 2015. Apart from these prostate cancers, colon cancers, bladder cancer are the most common type cancer. Depending upon the location of cancer the causes, symptoms and method of treatments varies. Carcinoma, Sarcoma, leukemia, lymphoma and melanoma are the types of cancer found in different organs.

Related Conferences:

International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016 Istanbul, Turkey;5th World conference on Cancer Therapy September 28-30 Atlanta USA; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; NEO 16 – New and Emerging Trends In Oncology May 19-21, 2016 San Francisco, USA; Cancer-2016 International Cancer Study and Therapy April 4-6, 2016 Baltimore, USA;. American Society of Clinical Oncology 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany

Track 12: Global Oncologists Meeting:

The cancer study is called as Oncology. A person who specializes in the study of oncology and treating people with cancer is known as oncologist. An oncologist shows dedicative care towards treatment once a person is suffering from cancer.

There are about 2900 oncologists in Germany, and 8000 oncologists in USA, around 9500 oncologists in Europe and 1500 eminent oncologists from different parts of Asia.

Related Conferences:

11th Asia-Pacific Oncologists Annual Meeting July 11-13, 2016 Kuala Lumpur, Malaysia; Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA; International Conference on Pancreatic and Colorectal Cancer March 29-30, 2016 Atlanta, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA; NEO 16 – New and Emerging Trends In Oncology May 19-21, 2016 San Francisco, USA; Cancer-2016 International Cancer Study and Therapy April 4-6, 2016 Baltimore, USA;. American Society of Clinical Oncology 2017 Annual Meeting October 24-26, 2016 San Francisco, USA; Post Congress Symposium in Cancer Diagnostics May 28, 2016 Gothenberg, Sweden; EMBO | EMBL Symposium: Tumor Microenvironment and Signaling April 3-6, 2016 Heidelberg, Germany

Track 13: Cancer Clinical Trails:

Clinical trials are research studies that involve people. Understanding what they are can help you decide if a clinical trial might be an option for you. Or maybe you have a friend or family member with cancer and are wondering if a clinical trial is right for them. Depending on product type and development stage, investigators initially enroll volunteers and/or patients into small pilot studies, and subsequently conduct progressively larger scale comparative studies. Clinical trials can vary in size and cost, and they can involve a single research center or multiple centers, in one country or in multiple countries. Clinical study design aims to ensure the scientific validity and reproducibility of the results. Cancer Diagnostics 2016 is a very prestigious gathering across global Cancer Conferences.

Matched content

Editor’s pick